SUMMARY. The development of a simple enzymatic method for the determination of blood and plasma pyridoxal 5' -phosphate (PLP) using pig heart apo-aspartate transaminase (apo-AST) is described. The technique requires three steps: (I) sample extraction using perchloric acid, (2) a binding step in which PLP in the sample extract is attached to the apo-AST and (3) the enzymatic assay of the reconstituted holo-AST. PLP extracts were analysed with and without a known concentration of added PLP to correct for variation in recovery between different specimens. Procedures are outlined for manual and automatic analysis of the PLP extracts. Using the KONE Clinical Analyser after the extraction step, it is possible to measure enzyme activity in 100 specimens (i.e. 400 tubes) in a 5 h period. Results are shown from 185 healthy women aged 20--45 years, in which plasma PLP concentrations ranged from 5 to 165 nmol/L, and 142 men and 56 women in Government service aged 17-64 years, whose plasma PLP ranged from 8 to 169 nmol/L. Values less than 20 nmol/L are believed to indicate vitamin B6 deficiency and the method is able to measure 5 nmol/L.
Vitamin B6 was discovered in 1934 and since that time many methods have been used to measure its status. Methods involving spectrophotometry, 1 tluorirnetry': 3 or microbiological assay" have been introduced to measure specific 86 vitamers, while others have assayed urinary 4-pyridoxic acids or more functional measurements, such as the tryptophan load test" or red cell enzyme activation tests."
The main biologically active form of vitamin 86 is pyridoxal 5' -phosphate (PLP). It functions as a cofactor for many enzymes involved in various biochemical systems, especially those associated with protein and amino acid metabolism. Studies have shown important relationships between deficiencies of this vitamin and several clinical disorders.~l() Direct assays to measure the concentration of PLP using PLP-dependent enzymes: tyrosine decarboxylase, 11 . 12 tryptophanase, 13 phosphorylase b,14 D-serine dehydratase;" gammacyanoaminobutyric acid apo-synthase" and aspartate transaminase!" have been proposed, but tyrosine decarboxylase is the most widely used enzyme at the present time. Other techniques such as cation exchange chromatography, 18 high performance liquid chromatography.!" thin layer electrophoresis/" and radioimmunoassay" have also been reported.
Many of the techniques are time-consuming and imprecise. The direct enzymatic assays are probably the most convenient and specific methods for routine use. We have developed a method using the enzyme apo-aspartate transaminase for measuring PLP in blood and plasma. The method is easy to perform, cheap, sensitive, requires only a basic spectrophotometer and does not require radioactive reagents. The basis of the method depends on the kinetic measurement of aspartate transaminase (AST) activity following the activation of pig heart apo-AST by PLP extracted from plasma or whole blood.
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Materials and methods
All reagents were of Analar grade or equivalent and purchased from Sigma unless otherwise stated.
REAGENTS
Tris-EDTA buffers, 109 mmol/L, pH 6,0, 7·0, 7·4, 7·8 Tris-EDTA buffers were prepared containing 17·2 g Tris (hydroxy methyl) amino-methane HCl and 2·54 g disodium ethylenediamine tetraacetate. The appropriate pH was obtained by addition of 1 mollL sodium hydroxide and made up to 1 litre with distilled water at 22°C. The buffers were stable for several weeks at 4°C.
Tris-EDTA buffer, 545 mmol/L, pH 6·2
Tris-EDTA buffer was prepared containing 86 g Tris HCl and 2·54 g Na2EDTA, adjusted to pH 6·2 with 1 mol/L NaOH and diluted to 1 litre with distilled water at 22°C. The buffer was stable for several weeks at 4°C.
2-oxoglutarate, 300 mmol/L
2·48 g sodium hydrogen 2-oxoglutarate was dissolved in 50 ml 109 mmol/L Tris-EDTA buffer pH 7·8 and the pH re-adjusted to pH 7·8 with 1 mol/L NaOH. The reagent was stable at 4°C for one month.
Substrate mixture (260 mmo/lL monopotassium L-aspartate, 226 ixmolll: NADHNa], 500 U/L malate dehydrogenase) 4·5 g potassium L-aspartate, 50 U MDH and 16 mg NADHNa2 were dissolved in 100 ml 109 mmol/L Tris-EDTA buffer pH 7·4. The solution was prepared freshly each day.
Stock standard PLP 10-15 umol/L 10 ul 8·1 mmol/L PLP (20 mg in 10 ml distilled water) was chromatographed on a silica gel 60F-254, sxm em TLC plates (0,25 mm thick, Merck) using MeOH:CHCl,:iso-amyl alcohol: diethylamine (VIV, 10:10:1·5:1·5, Aldrich) for 30 min at 22°C. The PLP band (Rf=0 '6) was scraped off the plate, extracted with 3 ml 109 mmol/L Tris-EDTA buffer pH 7·0 centrifuged and stored at -20°C for up to one month but discarded immediately after first use. Working standards were prepared by diluting five times with 109 mmol/L Tris-EDTA buffer pH 7·0 and the exact concentration obtained using the molar e~tinction coefficient of 4·9x1Q-' at 388 nm.
2Z
Sodium glutamate 200 mmol/L L-glutamic acid (1,47 g) and 0·56 g KOH were dissolved in distilled water, the pH adjusted to 8·3 with 1 rnol/L KOH and made up to 100 ml.
PREPARATION OF APO-ASPARTATE TRANSAMINASE (AST; EC 2.6.1.1) 0·2 ml of 109 mmollL Tris-EDTA buffer pH 7·8 was added to a bottle containing 500 units aspartate aminotransferase (Sigma lyophylised form, type II-A) and the solution transferred to a 50 ml conical flask. 1·0 ml of 200 mmol/L L-glutamate, pH 8·3 was added and the solution incubated at 37°C for 30 min. 1·0 ml of 150 mmol/L potassium phosphate buffer pH 4·8 was added and the mixture incubated at 37°C for a further 30 min. 7·5 ml of ice-cold saturated ammonium sulphate was added and the solution was left in an ice bath for 30 min to allow the enzyme to precipitate. After centrifugation at 2000xg for 15 min at 4°C, the precipitate was dissolved in 0·2 ml 109 mmollL Tris-EDTA buffer and the above steps were repeated twice. Finally, the protein precipitate was dissolved in 1·0 ml of 109 rnrnol/L Tris-EDTA buffer pH 7·8 and dialysed against the same buffer for at least 24 h in the cold room, changing the buffer once after 6 h. After dialysis, the apo-enzyme was diluted to a volume containing an activity which after saturation with PLP was 200 unitslml.
(1 unit will convert 1 urnol NADH to NAD per min in the linked assay for PLP). The apo-enzyme prepared in this way was sufficient for approximately 100 assays and was stable at 4°C for 8 weeks or several months at -20°C. Residual aspartate transaminase activity amounted to about 2% of the fully saturated apo-enzyme activity and was corrected for by a blank assay.
PREPARATION OF SAMPLES WITH AND
WITHOUT ADDED PLP STANDARD Blood specimens were collected using potassium EDTA anticoagulant. 10 ul working standard PLP (100 nmol/L) was added to one of two tubes, each containing 0·2 ml plasma, and 0·05 ml of 6 mol/L perchloric acid (BDH) was added whilst mixing. The supernatant was removed after centrifugation at 2000xg for 20 min, the precipitate was washed with 1·0 ml 100 mmol/L perchloric acid and recentrifuged. Both supernatants were combined and the solution was adjusted to pH 2·0-3·0 with 0·3 ml 1 mol/L potassium hydroxide to precipitate excess perchloric acid and the mixture left in an ice bath for 45 min to complete the precipitation. The supernatant containing PLP was removed after centrifugation at 2000xg for 5 min at 4°C and stored at 4°C up to 48 h.
In the case of whole blood, 0·2 ml of sample was mixed with the perchloric acid solution prior to the addition of the internal standard, 0·25 ml 1 mmol/L KOH was added to precipitate excess perchloric acid and 50 III water was added to correct for the volume difference but otherwise the procedure was identical to that for the plasma samples.
PLP in blood and plasma was shown to be stable for 72 h at room temperature (2D-22°C), approximately 5 days at 4°C and several months at -20°C. The perchloric acid extract from blood or plasma is also stable for several days at 4°C. No decrease in plasma or blood PLP was observed when samples were left at room temperature for 48 h exposed to normal laboratory light. Step I-Binding of PLP to the apo-aspartate transaminase. To 0·5 ml of 545 mmol/L Tris-EDTA buffer pH 6·2, in a 1 cm cuvette, was added 0·01 ml of apo-aspartate transaminase (approx. 2 units), followed by 0·1 ml of standard solutions or extract containing PLP. The mixture was incubated at 30°C for 90 min.
Step 2-Enzymatic determination. After preparation of the holoenzyme above, 2·3 ml of the substrate mixture (L-Aspartate-NADH-MDH) were added followed by 0·1 ml of 2-oxoglutarate solution to start the reaction. The decrease in optical density was monitored at 340 nm for 3 min.
(ii) Automated procedure The following procedure was developed for the KONE CD Compact Clinical Analyser.
Step 1 was modified by preparing a mixed reagent of 545 mmollL Tris-EDTA buffer pH 6·2 and the apo-aspartate transaminase preparation in the same ratio (50: I). 0·5 ml of this reagent was pipetted and mixed automatically with 0·1 ml of sample and incubated at 37°C for 60 min. In step 2, 0·1 ml of the holoenzyme preparation was mixed with 0·5 ml of a starter reagent containing the L-aspartate-NADH-MDH substrate mixture and 2-oxoglutarate reagents mixed in the proportion of 25:1.
(iii) Blank procedure To measure residual aspartate transaminase activity, in step 1 the extract solution was replaced by 0·1 ml of 109 mmol/L Tris-EDTA buffer pH 6·0 and the resultant activity was subtracted from the change in absorbance of the test extracts.
(iv) Standard Curve
Volumes of 10, 20, 30 or 40 III of working standard were mixed with 1 ml 109 mmol/L Tris-EDTA buffer pH 6·0 to give the following approximate concentrations 20, 40, 60 and 80 nmollL. Volumes of 0·2 ml of each of these standards were then diluted in 1·35 ml of the same buffer to simulate the blood extraction procedure.
SUBJECTS
Blood samples were obtained from two groups of subjects who were attending healthscreening clinics. The first group were young women aged 20-45 years attending a BUPA clinic. A fasting blood sample was obtained and a questionnaire completed.P Results from all persons recently consuming vitamin B6 were excluded from the reference range shown. Samples were posted to Birmingham, mostly being received within 24 h. The second group were blood samples obtained from Government employees, aged 16-65 years, receiving a routine health screen. Subjects were not fasted and only information on age and sex was available. All samples arriving within 72 h of collection were analysed.
Results
It was observed that the binding of PLP to apo-aspartate transaminase was not only dependent on pH, temperature and time but also subject to interference by other components in the incubation mixture. In the method for plasma sample preparation, we used a fixed volume of 0·3 ml of 1 mol/L potassium hydroxide to remove the excess amount of perchloric acid. This we found more convenient than titrating the extract to a certain pH, especially when routinely handling many specimens and also, the extract was intentionally left acidic because PLP is more stable at an acidic pH. PLP was then incubated with the apoaspartate transaminase using a high concentration of Tris-EDTA buffer (545 mmollL) to reduce any variation in pH due to varying amounts of perchloric acid. Optimal conditions for the enzyme reaction were established as follows.
BINDING OF PLP TO APO-ENZYME
Effect of buffer concentration
0) ranging from 100 to 1000 mmollL at 100 mmol/L intervals. The reconstituted holoenzyme was then assayed using the standard conditions described in step 2 of the enzyme assay in the Methods section. There was no change in enzyme activity over the range of buffer concentrations studied and for all cases the absorbance (OD) change per minute fell within the range 0·186±0·005. Figure 1 demonstrates the effect of pH on the binding of PLP to apo-aspartate transaminase.
Effect of pH
0.4
The pH of the pre-incubation buffer was varied from 3·0 to 8·0 by adjusting the 545 mmol/L Tris-EDTA buffer (pH 6·2) with 1 mol/L perchloric acid or I mol/L NaOH. A broad plateau of optimal activity was demonstrated over the range 3·9 to 6·9 and from this experiment a pH of 6·2 was chosen for the buffer in the pre-incubation stage. It was found that this pH decreased to about 5·9 on addition of acidic plasma extracts. However, because of the broad pH optimum for the binding reaction, this change in pH did not impair the formation of the holo-enzyme. The pH in the assay stage of the holo-enzyme was also decreased slightly (approximately 0·2 pH units). Figure 2 shows that the presence of the Laspartate-NADH-MDH mixture during the pre-incubation of a standard solution of PLP and the apo-aspartate transaminase resulted in much slower activation of the apoenzyme, which had not reached a plateau value after 60 min. In contrast, binding of PLP to the apoenzyme with none of the other assay components present, resulted in maximal activity being reached in about 10 min.
Effect of substrates
Effect of plasma components
Plasma or blood extracts contain other components besides PLP and it was found that A plasma extract (0·1 mL) was incubated for 60 min at 37°C with 0·5 mL 545 mmoUL Tris-EDTA buffers at different pHs (prepared as described in text). The mixtures were then assayed as described in step 2 of the enzyme assay. reactivation of apo-aspartate transaminase by blood extracts was not as rapid as that obtained with standard PLP alone. Figure 3 shows the influence of temperature on the time taken for a plasma extract of PLP to achieve maximal binding to the apo-enzyme preparation. Reactivation was essentially complete after 1 h at 37°C or 90 min at 30°C. Likewise, reactivation at room temperature (22°C) also required 90 min. These conditions should be compared with the 10 min required when using standard PLP solution, as shown in Fig. 2 , and indicate that the blood extracts contain components which delay the reactivation of the apo-enzyme. In addition, it was found that when standard PLP was added to plasma, either before or after extraction, 70-90% was recovered. For this reason it was necessary to incorporate an internal standard into the procedure. The coefficient of variation when standard was added to a plasma sample and assayed 20 times under standard condition was 5·6%. Standard conditions for enzymatic assay were used and a plasma extract was selected which had been previously shown to contain a higher than normal PLP concentration. Figure 4 illustrates the wide range of pH conditions which supported optimal activity of holo-aspartate transaminase. A plateau of activity was demonstrated between pH 6·0-8·0. Although the ionic strength of the buffer was not maintained constant over the pH range, it
Effect of pH of the assay buffer
Standard curve
The standard curve of aqueous PLP standards is linear up to concentrations of at least 100 nmol/L in the standard assay. The OD change per 10 nrnol/L PLP standard was 0·0085/min in the standard procedure.
Accuracy and precision
PLP standards used to calibrate the assay were purified using TLC and quantified using the extinction coefficient. The major impurity removed by the TLC purification was pyridoxamine 5'-phosphate (PMP) which was found to be present in amounts of up to 35% in the Sigma PLP standard used. PMP is also capable of reactivating apo-aspartate transaminase and therefore by omitting the TLC separation, results for PLP standards are reduced by up to 35% since the concentration of PLP is calculated from the OD at 388 nm while PMP absorbs maximally around 315 nm,zz
The use of internal PLP standards was also necessary to compensate for the varying inhibitory properties of different blood extracts on holo-aspartate transaminase activity.
The coefficient of variation (CV) for interassay precision of the semi-automated assay on a 30 nmoUL quality control standard PLP was 8·4%. Likewise, the CV for intra-assay precision of low and high plasma extracts containing internal standard were 6·9% and 5·5% respectively. The method is sufficiently sensitive to detect nmolar concentrations in blood or 100 fmols per assay tube.
Discussion
The method described is similar in principle to that originally published by Walsh 17 in which he used apo-aspartate transaminase prepared from a wheat germ extract. We are not sure why this method has been neglected by workers in this field, since the enzyme is well characterised, relatively easy to measure and a convenient source of the enzyme is commercially available as pig heart halo-enzyme. We have improved the simplicity and sensitivity of the method and have determined optimal conditions for the reactivation of the apo-enzyme when using plasma or whole blood extracts of PLP. Perchloric acid was used to precipitate protein in blood or plasma rather than TCA, since the latter would require an organic solvent to remove excess acid. Tris-EDTA buffers were used for both the reactivation step and the assay of the reconstituted holo-enzyme since it was found to give the highest reactivation rate. 24 The ACB Working Party's recommended assay for aspartate transaminase suggested 109 mmollL Tris-EDTA buffer pH 7,8.
24 A higher molarity Tris-EDTA buffer, 545 mrnol/L (pH 6,2), was chosen for the reactivation step to ensure that addition of the acidic extract (pH 2·0-3·0) did not reduce the pH to below 3·9. The final molarity and pH of the assay mixture will be the result of mixing 0·5 ml of a 545 mrnol/L Tris buffer pH 6·2, 0·1 ml of the acidic extract and 2·3 ml of 109 mmol/L Tris buffer pH 7·4. However, because of the broad pH and molarity optimum for the assay of aspartate transaminase, the final pH of 6·0 allowed optimal activity of the enzyme. Internal PLP standards are taken through the entire assay procedure and will thus compensate for any small differences in assay conditions between batches of apoenzyme and sample extracts.
We have demonstrated that it is important to pre-incubate the apo-enzyme with PLP in the absence of the other substrates of the aspartate transaminase assay. It seems probable that Laspartate delays, and possibly inhibits, the binding of PLP to the apo-enzyme, either by steric hindrance and blocking the entry of PLP to its binding site or by weakening the bonds between PLP and the enzyme.P The slower reactivation rate in the presence of the aspartate-NADH-MDH mixture is very marked, as shown in Fig. 2 , and may have important implications in the routine assay for vitamin B6 status using red cell aspartate transaminase and PLP as an activator. It may be that the apo-enzyme should always be preincubated with the PLP before addition of the rest of the assay components.
It was also found that a plasma extract containing added PLP causes less reactivation of apo-aspartate transaminase than an equivalent concentration of an aqueous standard and for this reason internal standards were needed to measure PLP in all samples. Unknown components in the extracts also appear to interfere with the rate of binding of PLP to the apo-aspartate transaminase and thus delay the time when maximal reactivation is reached. The reactivation rate was increased by increasing the pre-incubation temperature to 37°C but, nevertheless, 60 min was still required to obtain full reactivation (Fi 9 . 3).
Other workers/' I have also found similar lower recoveries of standard PLP when added to plasma extracts using the tyrosine decarboxylase reactivation technique. Substances such as the amino acids, aspartate and glutamate and the anion, phosphate, 17, 25 are known to affect the nature of holo-aspartate transaminase. Our observations suggest that phosphate in plasma extracts, in particular, is mainly responsible for the inhibitory effect on AST activity by reducing the PLP in extracts which binds to apo-AST. Residual perchloric acid in the extracts is not· responsi ble for the lowered recoveries since aqueous standards taken through the perchloric acid extraction were fully recovered. The problems of incomplete recovery may explain some of the differences in reference ranges reported by different workers.
The method is also capable of measuring PMP by using the appropriate standard in place of PLP. That is, the method does not differentiate between the two coenzymes but as PMP only represents 2% of the B6 vitamers in human plasma" the error is only small.
We have used the above method to measure plasma PLP in two population groups attending health-screening clinics. The data are shown in Table 1 for men and women separately, together with results reported by other workers for some of the other enzymatic methods which are or have been used. In our hands, mean values for plasma PLP obtained by the AST reactivation method fell between 42-53 nx and most values fell below 100 nx, Approximately 4% of results, however, were between 100-200 nM, although a smaller proportion (1-2%) lay above this range at concentrations reaching as high as 1094 nM. However, when information was available on dietary supplements all values greater than 200 nM were from persons taking vitamin B6 and these were excluded from the reference ranges (Table 1) .
Workers have tended to regard 20 nM as the lower limit of the normal range.r" By this method and the equipment described, it is possible to measure values as low as 5 nM which should indicate vitamin B6 deficiency. Further studies are needed to validate this point since dietary information was not obtained in this work.
Although mean values for male and female Government employees were higher than the mean for the group of young women, the difference was only significant for the men (P<O·Ol). The difference between the means for male and female Government employees was not significant. Many workers have reported that plasma PLP is higher in men than women. 27 , 28 There was no relationship between age and plasma PLP in any of the three groufs. This is in contrast to reports by other workers/ -311 but such reports usually include a high proportion of persons above the age of 65 years.
The range of values reported by other workers using enzymic reactivation techniques also tended to lie below 200 nM, but large differences do exist both between the means reported by other workers and with our own results. In general, results are reported on the basis of small numbers of individuals and without information on the intake of vitamin B6. Either of these reasons may account for the large differences between different workers.
